[go: up one dir, main page]

RU2010145439A - MEANS FOR TREATMENT OF LIVER DISEASES CAUSED BY EXPOSURE TO CHEMICAL OR BIOLOGICAL AGENTS - Google Patents

MEANS FOR TREATMENT OF LIVER DISEASES CAUSED BY EXPOSURE TO CHEMICAL OR BIOLOGICAL AGENTS Download PDF

Info

Publication number
RU2010145439A
RU2010145439A RU2010145439/15A RU2010145439A RU2010145439A RU 2010145439 A RU2010145439 A RU 2010145439A RU 2010145439/15 A RU2010145439/15 A RU 2010145439/15A RU 2010145439 A RU2010145439 A RU 2010145439A RU 2010145439 A RU2010145439 A RU 2010145439A
Authority
RU
Russia
Prior art keywords
exposure
chemical
biological agents
treatment
diseases caused
Prior art date
Application number
RU2010145439/15A
Other languages
Russian (ru)
Inventor
Виктор Вениаминович Тец (RU)
Виктор Вениаминович Тец
Георгий Викторович Тец (RU)
Георгий Викторович ТЕЦ
Константин Андреевич Краснов (RU)
Константин Андреевич Краснов
Original Assignee
Виктор Вениаминович Тец (RU)
Виктор Вениаминович Тец
Георгий Викторович Тец (RU)
Георгий Викторович ТЕЦ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Виктор Вениаминович Тец (RU), Виктор Вениаминович Тец, Георгий Викторович Тец (RU), Георгий Викторович ТЕЦ filed Critical Виктор Вениаминович Тец (RU)
Priority to RU2010145439/15A priority Critical patent/RU2010145439A/en
Priority to ES11839641T priority patent/ES2730943T3/en
Priority to US13/883,854 priority patent/US8999959B2/en
Priority to PL11839641T priority patent/PL2638900T3/en
Priority to EP11839641.5A priority patent/EP2638900B1/en
Priority to PCT/RU2011/000792 priority patent/WO2012064221A1/en
Publication of RU2010145439A publication Critical patent/RU2010145439A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Средство для лечения поражений печени, вызванных воздействием химических или биологических агентов, отличающееся тем, что оно представляет собой 1-(4-бромфенил)-6-гидрокси-5-нитрозо-1,2,3,4-тетрагидро-пиримидин-2.4-дион: !! или его соли общей формулы: ! , ! где X выбран из ряда: Na+, K+, Li+, NH4 +, NH2CONH3 + или другой фармакологически приемлемый катион. An agent for treating liver damage caused by exposure to chemical or biological agents, characterized in that it is 1- (4-bromophenyl) -6-hydroxy-5-nitroso-1,2,3,4-tetrahydropyrimidin-2.4- dion: !! or its salts of the general formula:! ! where X is selected from the series: Na +, K +, Li +, NH4 +, NH2CONH3 + or another pharmacologically acceptable cation.

Claims (1)

Средство для лечения поражений печени, вызванных воздействием химических или биологических агентов, отличающееся тем, что оно представляет собой 1-(4-бромфенил)-6-гидрокси-5-нитрозо-1,2,3,4-тетрагидро-пиримидин-2.4-дион:An agent for treating liver damage caused by exposure to chemical or biological agents, characterized in that it is 1- (4-bromophenyl) -6-hydroxy-5-nitroso-1,2,3,4-tetrahydropyrimidin-2.4- dion:
Figure 00000001
Figure 00000001
или его соли общей формулы:or its salts of the General formula:
Figure 00000002
,
Figure 00000002
,
где X выбран из ряда: Na+, K+, Li+, NH4+, NH2CONH3+ или другой фармакологически приемлемый катион. where X is selected from the series: Na + , K + , Li + , NH 4 + , NH 2 CONH 3 + or another pharmacologically acceptable cation.
RU2010145439/15A 2010-11-08 2010-11-08 MEANS FOR TREATMENT OF LIVER DISEASES CAUSED BY EXPOSURE TO CHEMICAL OR BIOLOGICAL AGENTS RU2010145439A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
RU2010145439/15A RU2010145439A (en) 2010-11-08 2010-11-08 MEANS FOR TREATMENT OF LIVER DISEASES CAUSED BY EXPOSURE TO CHEMICAL OR BIOLOGICAL AGENTS
ES11839641T ES2730943T3 (en) 2010-11-08 2011-10-10 Drug to treat liver lesions caused by the action of chemical or biological agents
US13/883,854 US8999959B2 (en) 2010-11-08 2011-10-10 Drug for treating liver lesions caused by the action of chemical or biological agents
PL11839641T PL2638900T3 (en) 2010-11-08 2011-10-10 Drug for treating liver lesions caused by the action of chemical or biological agents
EP11839641.5A EP2638900B1 (en) 2010-11-08 2011-10-10 Drug for treating liver lesions caused by the action of chemical or biological agents
PCT/RU2011/000792 WO2012064221A1 (en) 2010-11-08 2011-10-10 Drug for treating liver lesions caused by the action of chemical or biological agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010145439/15A RU2010145439A (en) 2010-11-08 2010-11-08 MEANS FOR TREATMENT OF LIVER DISEASES CAUSED BY EXPOSURE TO CHEMICAL OR BIOLOGICAL AGENTS

Publications (1)

Publication Number Publication Date
RU2010145439A true RU2010145439A (en) 2012-05-20

Family

ID=46051175

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010145439/15A RU2010145439A (en) 2010-11-08 2010-11-08 MEANS FOR TREATMENT OF LIVER DISEASES CAUSED BY EXPOSURE TO CHEMICAL OR BIOLOGICAL AGENTS

Country Status (6)

Country Link
US (1) US8999959B2 (en)
EP (1) EP2638900B1 (en)
ES (1) ES2730943T3 (en)
PL (1) PL2638900T3 (en)
RU (1) RU2010145439A (en)
WO (1) WO2012064221A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2595868C1 (en) * 2015-03-27 2016-08-27 Виктор Вениаминович Тец Drug preparation with hepatoprotective activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2333537A1 (en) 1998-05-26 1999-12-02 Rimma Iliinichna Ashkinazi N-substituted derivatives of 5-oxyiminobarbituric acid
RU2188196C2 (en) 1998-05-26 2002-08-27 Ашкинази Римма Ильинична N-substituted derivatives of 5-hydroxyimino-barbituric acid
AU2001282162A1 (en) 2000-07-05 2002-01-14 Biotie Therapies Corp. Inhibitors of copper-containing amine oxidases

Also Published As

Publication number Publication date
EP2638900A4 (en) 2014-04-02
PL2638900T3 (en) 2019-11-29
ES2730943T3 (en) 2019-11-13
US20130237704A1 (en) 2013-09-12
EP2638900B1 (en) 2019-05-15
US8999959B2 (en) 2015-04-07
EP2638900A1 (en) 2013-09-18
WO2012064221A1 (en) 2012-05-18

Similar Documents

Publication Publication Date Title
CY1122266T1 (en) 3-AMINOCYCLALKYL COMPOUNDS AS ROR-GAMMA-T INHIBITORS AND USES THEREOF
CY1124519T1 (en) SOLID AND PHARMACEUTICAL FORMS OF (S)-4-(8-AMINO-3-(1-(BUT-2-YNOYL)PYRROLIDIN-2-YL)IMIDAZO[1,5-α|PYZIN-1-YL)- N-(PYRIDIN-2-YL) BENZAMIDO
CY1119533T1 (en) NEW THERAPEUTIC FACTORS
CY1122272T1 (en) 3-CYCLOHEXENYL AND CYCLOHEXYL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
GT201600123A (en) SYK INHIBITORS
UA111770C2 (en) BROMDOMEN INHIBITORS
UA109667C2 (en) HINAZOLINE-4 (3H) -ONE DERIVATIVES USED AS PI3-KINASE INHIBITORS
EA201170832A1 (en) PURINE CONNECTIONS
EA201100750A1 (en) SUBSTITUTED DIOXOPIPERIDINYL-PHTHALIMIDE DERIVATIVES
ECSP099786A (en) PIRAZOL AMIDAS OF CARBOXYL ACID USEFUL AS MICROBICIDES
TR201905814T4 (en) Biprazole salt as a jack inhibitor.
DOP2015000305A (en) BROMODOMINIUM INHIBITORS
EA201400735A1 (en) DERIVATIVES ALPHA-AMINO BORONIC ACID, SELECTIVE INHIBITORS IMMUNOPROTEASOMA
MX2019008122A (en) Heterocycle amines and uses thereof.
EA201300684A1 (en) DERIVATIVES OF 6-AMINO-2-PHENYLAMINO-1H-BENZIMIDAZOLE-5-CARBOXAMIDE AND THEIR APPLICATION AS AN INHIBITORS OF MICROSOMIC PROSTAGLANDIN-E2-SYNTHASE-1
EA201590748A1 (en) ANTI-VIRUS CONNECTIONS AGAINST RSV
MX374513B (en) HETEROARYL ACID MORPHOLINONE COMPOUNDS AS MDM2 INHIBITORS FOR CANCER TREATMENT.
EA201291300A1 (en) DERIVATIVES OF NAFT-2-LUCUS ACID FOR THE TREATMENT OF AIDS
CY1116168T1 (en) TOY CCR3 HYPERCELLULATORS AND SALT SALTS
EA201301301A1 (en) TIAZOLE DERIVATIVES
EA201790779A1 (en) SUBSTITUTED AMINOPURIN COMPOUNDS, THEIR COMPOSITIONS AND METHODS OF TREATMENT USING SUCH CONNECTIONS
CR20140135A (en) NEW DERIVATIVES OF ARIL-QUINOLINA
AR077080A1 (en) COMPOUNDS OF 2,3-DIHIDRO-1H-INDENO
EA201491276A1 (en) NEW BENZILSULPHONAMIDE DERIVATIVES SUITABLE FOR USE AS MOGAT-2 INHIBITORS
EA201200087A1 (en) 2-CARBOXAMIDES CYCLOAMINUM CEAMS WHICH ARE PI3K INHIBITORS